Blog
RSS FeedPosted by Michael Wonder on 31 Jan 2017
Schedule of Pharmaceutical Benefits - 1 February 2017 update
1 February 2017 - The 1 February 2017 issue of the Schedule of Pharmaceutical Benefits sees a number of new ...
Posted by Michael Wonder on 31 Jan 2017
New Zealand Pharmaceutical Schedule - 1 February 2017
1 February 2017 - The February 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 Jan 2017
Patients battling deadly ovarian, lung cancer to have affordable access to new drugs
31 January 2017 - Sick patients battling deadly cancers will have affordable access to new drugs which usually cost more ...
Posted by Michael Wonder on 30 Jan 2017
CADTH recommends UCB's Brivlera
25 January 2017 - CADTH's first outcome for 2017 is in favour of the reimbursement of brivaracetam. ...
Posted by Michael Wonder on 30 Jan 2017
Rise in deadly W strain of Meningococcal disease prompts calls for national approach
30 January 2017 - A national approach to the deadly W strain of Meningococcal disease is being considered by Australia's ...
Posted by Michael Wonder on 30 Jan 2017
Cancer drugs price rise 'costing NHS millions'
29 January 2017 - UK prices for generic cancer drugs have risen sharply in the past five years, restricting their ...
Posted by Michael Wonder on 29 Jan 2017
Check your health insurance because extras cover may not be worth it, say experts
29 January 2017 - Private health insurance members with extras cover should be doing a simple maths equation to work ...
Posted by Michael Wonder on 27 Jan 2017
Health insurers, customers hope for a win on premium increases
27 January 2017 - New health minister Greg Hunt could look to score a “win” with consumers and approve the ...
Posted by Michael Wonder on 27 Jan 2017
Post-market review of ezetimibe – draft report
27 January 2017 - Public consultation on the draft Report to the PBAC of the post-market review of ezetimibe is ...
Posted by Michael Wonder on 27 Jan 2017
Recommendations made by the PBAC - December 2016
27 January 2016 - The outcomes from the December 2016 PBAC meeting are now available. ...
Posted by Michael Wonder on 26 Jan 2017
Final yes from NICE for Gilead’s Epclusa
26 January 2017 - NICE has now published final guidance endorsing Epclusa as an option for the treatment of adults ...
Posted by Michael Wonder on 26 Jan 2017
Approval of proposal for clostridium botulinum type A toxin (Botox) in DHB hospitals
26 January 2017 - PHARMAC is pleased to announce the approval of an agreement with Allergan to amend the contractual ...
Posted by Michael Wonder on 25 Jan 2017
NICE guidance on ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia in the presence of 17p deletion or TP53 mutation
25 January 2017 - NICE published guidance that recommended ibrutinib for chronic lymphocytic leukaemia in adults who have had at ...
Posted by Michael Wonder on 25 Jan 2017
Bupa warns health insurers face unsustainable cost increases
26 January 2017 - Bupa has warned the Turnbull government that affordability concerns have driven the private health insurance sector ...
Posted by Michael Wonder on 25 Jan 2017
Woman plans to sell home to pay for pancreatic cancer treatment
24 January 2017 - A woman has been forced to sell her paintings, jewellery and now even her house after ...